1 – 10 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
- Neuropeptide Y increases in vivo hippocampal extracellular glutamate levels through Y-1 receptor activation
- 2011
- Increased hippocampal noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbic seizure model
- 2010
- Pharmacological and neurochemical characterization of the involvement of hippocampal adrenoreceptor subtypes in the modulation of acute limbic seizures
- Astrocytic beta(2)-adrenergic receptors: from physiology to pathology
- 2009
- Intrastrain differences in seizure susceptibility, pharmacological response and basal neurochemistry of Wistar rats
- Anti-epileptic effects of vagus nerve stimulation in the focal pilocarpine model
- 2008
- Seizure activity and changes in hippocampal extracellular glutamate, GABA, dopamine and serotonin
- Direct enhancement of hippocampal dopamine or serotonin levels as a pharmacodynamic measure of combined antidepressant-anticonvulsant action
- 2007
- Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y
- 2006
- Substantia nigra is an anticonvulsant site of action of topiramate in the focal pilocarpine model of limbic seizures